Pediatric Neurogenetic Diagnosis Support Platform
Recruiting
N/A
Interventional Study
Genetic Disease
Neurogenetic Disorders
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 9 (estimated)
- Sponsor
- Universidad Nacional Andres Bello · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study evaluates a diagnostic support platform, DIAGEN-IA, designed to identify pediatric neurological diseases with a genetic basis. Conducted at Carlos Van Buren Hospital in Chile, it aims to determine if the platform reduces inappropriate referrals to clinical geneticists, improves diagnostic evaluations, enhances referral quality, and increases user satisfaction. A prospective before-and-a…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Neuropediatricians working in the Carlos Van Buren Hospital.
* Participants providing care to pediatric patients (under 18 years of age).
* Native Spanish speakers or those with certified C1-level Spanish proficiency according to the Common European Framework of Reference for …
Contacts